Search

Faculty information

We are honored that you have agreed to be part of the faculty for the Highlights of Past EHA (HOPE) MENA 2023, to be held on November 4, 2023 in Antalya, Türkiye.

Read more

Registration

Register here

Individual registrationHybrid registration includes:

In-person access to the scientific and educational sessions of the meeting
Access to the virtual platform
Meeting materials
Coffee/tea breaks on February 6-8, 2025 and lunches on February 7-8,2025
Access to the Welcome Reception
Access to the Poster Session(s) and viewing…

Read more

Faculty information

We are honored that you have agreed to be part of the faculty for the Highlights of Past EHA (HOPE) Latin America (LA) 2023, to be held on October 26, 2023 in São Paulo, Brazil.

Read more

Faculty Information

We are honored that you have agreed to be a part of the faculty for the EHA-KCS Hematology Tutorial – Recent Advances in Lymphoid and Myeloid Malignancies, scheduled to be held on September 13-14, 2024 in Almaty, Kazakhstan.

Read more

Faculty Information

We are honored that you have agreed to be a part of the faculty for the EHA-TSH Hematology Tutorial on T Cell Lymphomas, scheduled to be held on June 29-30, 2024 in Ankara, Türkiye.

Read more

Sponsors

If you want to go fast, go alone. If you want to go far, go together. We aim for long-term relationships with our partners and sponsors.

Read more

EU funding approved for TOLERATE

On April 1, the European Commission approved funding for the TOLERATE training network, proposed by a KU Leuven-led consortium including EHA.

Read more

Stopping tyrosine kinase inhibitors in a very large cohort of European chronic myeloid leukemia patients: results of the EURO-SKI trial

Tyrosine kinase inhibitors (TKI) have substantially improved survival in patients with chronic myeloid leukemia in chronic phase. However, treatment is in clinical practice considered life-long.

Read more